Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2018 | Jul. 25, 2018 | |
Document And Entity Information | ||
Entity Registrant Name | BOVIE MEDICAL CORP | |
Entity Central Index Key | 719,135 | |
Document Type | 10-Q | |
Document Period End Date | Jun. 30, 2018 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity Well-known Seasoned Issuer | No | |
Entity Voluntary Filers | No | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 33,203,517 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2,018 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2018 | Dec. 31, 2017 |
Current assets: | ||
Cash and cash equivalents | $ 7,875 | $ 9,949 |
Restricted cash | 660 | 719 |
Trade accounts receivable, net of allowance of $180 and $204 | 5,592 | 4,857 |
Inventories, net | 7,533 | 6,526 |
Prepaid expenses and other current assets | 568 | 496 |
Total current assets | 22,228 | 22,547 |
Property and equipment, net | 6,314 | 6,408 |
Brand name and trademark | 1,510 | 1,510 |
Purchased technology and license rights, net | 235 | 179 |
Goodwill | 185 | 185 |
Deposits | 115 | 92 |
Other assets | 67 | 67 |
Total assets | 30,654 | 30,988 |
Current liabilities: | ||
Accounts payable | 2,745 | 1,583 |
Accrued severance and related | 439 | 1,242 |
Accrued payroll | 394 | 447 |
Current portion of mortgage note payable | 239 | 239 |
Accrued and other liabilities | 2,420 | 2,462 |
Total current liabilities | 6,237 | 5,973 |
Mortgage note payable, net of current portion | 2,335 | 2,455 |
Note payable | 140 | 140 |
Deferred tax liability | 368 | 368 |
Derivative liabilities | 0 | 20 |
Total liabilities | 9,080 | 8,956 |
STOCKHOLDERS’ EQUITY | ||
Common stock, $0.001 par value; 75,000,000 shares authorized; 33,055,131 issued and 32,912,556 outstanding as of June 30, 2018 and 75,000,000 shares authorized; 33,021,170 issued and 32,878,091 outstanding as of December 31, 2017, respectively | 33 | 33 |
Additional paid-in capital | 51,244 | 50,495 |
Accumulated deficit | (29,703) | (28,496) |
Total stockholders’ equity | 21,574 | 22,032 |
Total liabilities and stockholders’ equity | $ 30,654 | $ 30,988 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Jun. 30, 2018 | Dec. 31, 2017 |
Stockholders' equity: | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 75,000,000 | 75,000,000 |
Common stock, shares issued (in shares) | 33,055,131 | 33,021,170 |
Common stock, shares outstanding (in shares) | 32,912,556 | 32,878,091 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |
Income Statement [Abstract] | ||||
Sales | $ 11,475 | $ 9,799 | $ 21,391 | $ 18,188 |
Cost of sales | 5,198 | 4,757 | 10,124 | 8,920 |
Gross profit | 6,277 | 5,042 | 11,267 | 9,268 |
Other costs and expenses: | ||||
Research and development | 816 | 696 | 1,378 | 1,405 |
Professional services | 681 | 480 | 1,187 | 870 |
Salaries and related costs | 2,118 | 2,243 | 4,234 | 4,703 |
Selling, general and administrative | 2,929 | 2,929 | 5,599 | 5,333 |
Total other costs and expenses | 6,544 | 6,348 | 12,398 | 12,311 |
Loss from operations | (267) | (1,306) | (1,131) | (3,043) |
Interest expense, net | (38) | (36) | (72) | (67) |
Change in fair value of derivative liabilities | 46 | 38 | 20 | 126 |
Total other income (expense), net | 8 | 2 | (52) | 59 |
Loss before income taxes | (259) | (1,304) | (1,183) | (2,984) |
Income tax expense | 13 | 4 | 24 | 9 |
Net loss | $ (272) | $ (1,308) | $ (1,207) | $ (2,993) |
Loss per share | ||||
Basic (in dollars per share) | $ (0.01) | $ (0.04) | $ (0.04) | $ (0.10) |
Diluted (in dollars per share) | $ (0.01) | $ (0.04) | $ (0.04) | $ (0.10) |
Weighted average number of shares outstanding - basic (in shares) | 32,890 | 30,860 | 32,884 | 30,860 |
Weighted average number of shares outstanding - dilutive (in shares) | 32,890 | 30,860 | 32,884 | 30,860 |
CONSOLIDATED STATEMENT OF CHANG
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Deficit |
Beginning balance (in shares) at Dec. 31, 2016 | 976 | 30,860 | |||
Beginning balance, amount at Dec. 31, 2016 | $ 26,223 | $ 1 | $ 31 | $ 49,625 | $ (23,434) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock based compensation | 341 | 341 | |||
Net loss available to common shareholders | (2,993) | (2,993) | |||
Ending balance, amount at Jun. 30, 2017 | 23,571 | $ 1 | $ 31 | 49,966 | (26,427) |
Ending balance (in shares) at Jun. 30, 2017 | 976 | 30,860 | |||
Beginning balance (in shares) at Dec. 31, 2017 | 0 | 32,878 | |||
Beginning balance, amount at Dec. 31, 2017 | 22,032 | $ 0 | $ 33 | 50,495 | (28,496) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Options exercised (in shares) | 37 | ||||
Options exercised | 83 | 83 | |||
Warrant exercised (in shares) | 40 | ||||
Warrants exercised | 95 | 95 | |||
Stock based compensation | 749 | 749 | |||
Stock swap to acquire options and warrants (in shares) | (42) | ||||
Stock swap to acquire options and warrants | (178) | (178) | |||
Net loss available to common shareholders | (1,207) | (1,207) | |||
Ending balance, amount at Jun. 30, 2018 | $ 21,574 | $ 0 | $ 33 | $ 51,244 | $ (29,703) |
Ending balance (in shares) at Jun. 30, 2018 | 0 | 32,913 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2018 | Jun. 30, 2017 | |
Cash flows from operating activities | ||
Net loss | $ (1,207) | $ (2,993) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 371 | 356 |
Provision for inventory obsolescence | (52) | 83 |
(Loss) gain on disposal of property and equipment, net | (1) | 2 |
Stock based compensation | 749 | 341 |
Change in fair value of derivative liabilities | (20) | (126) |
Provision for allowance for doubtful accounts | 82 | 159 |
Changes in current assets and liabilities: | ||
Trade receivables | (817) | (355) |
Prepaid expenses | (72) | (125) |
Inventories | (955) | (1,507) |
Deposits and other assets | (23) | (72) |
Accounts payable | 1,162 | 471 |
Accrued and other liabilities | (898) | (128) |
Net cash used in operating activities | (1,681) | (3,894) |
Cash flows from investing activities | ||
Purchases of technology, property and equipment | (332) | (151) |
Net cash used in investing activities | (332) | (151) |
Cash flows from financing activities | ||
Repayment of mortgage note payable | (120) | (119) |
Net cash used in financing activities | (120) | (119) |
Net change in cash, cash equivalents and restricted cash | (2,133) | (4,164) |
Cash, cash equivalents and restricted cash, beginning of period | 10,668 | 15,235 |
Cash, cash equivalents and restricted cash, end of period | 8,535 | 11,071 |
Cash paid for: | ||
Interest paid | $ 72 | $ 67 |
BASIS OF PRESENTATION
BASIS OF PRESENTATION | 6 Months Ended |
Jun. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BASIS OF PRESENTATION | BASIS OF PRESENTATION Unless the context otherwise indicates, the terms “we,” “our,” “us,” “Bovie,” and similar terms refer to Bovie Medical Corporation and its consolidated subsidiaries. The accompanying unaudited consolidated financial statements have been prepared based upon SEC rules that permit reduced disclosure for interim periods. For a more complete discussion of significant accounting policies and certain other information, please refer to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2017 . These financial statements reflect all adjustments that are necessary for a fair presentation of results of operations and financial condition for the interim periods shown, including normal recurring accruals and other items. The results for the interim periods are not necessarily indicative of results for the full year. On July 9, 2018, we entered into a definitive agreement with Specialty Surgical Instrumentation Inc., a subsidiary of Symmetry Surgical Inc. (“Symmetry”), pursuant to which the Company will divest and sell the Core business segment, including the Bovie ® brand and trademarks to Symmetry for gross proceeds of $97 million in cash. The asset purchase agreement was approved by the Company’s Board of Directors and is subject to customary closing conditions, including approval by the Company’s stockholders, and expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The Company is retaining and will continue to operate its Advanced Energy and OEM businesses, its facilities in Clearwater, FL and Sofia, Bulgaria, and certain intellectual property related to specialty generators. |
INVENTORIES
INVENTORIES | 6 Months Ended |
Jun. 30, 2018 | |
Inventory Disclosure [Abstract] | |
INVENTORIES | INVENTORIES Inventories are stated at the lower of cost or market. Cost is determined on a first in, first out basis. Finished goods and work-in-process inventories include material, labor and overhead costs. Factory overhead costs are allocated to inventory manufactured in-house based upon labor hours. Inventories consisted of the following: (In thousands) June 30, December 31, Raw materials $ 6,093 $ 5,163 Finished goods 3,301 3,276 Gross inventories 9,394 8,439 Less: reserve for obsolescence (1,861 ) (1,913 ) Net inventories $ 7,533 $ 6,526 |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 6 Months Ended |
Jun. 30, 2018 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS | INTANGIBLE ASSETS Intangible assets consisted of the following: (In thousands) June 30, December 31, Brand name and trademark (life indefinite) $ 1,510 $ 1,510 Purchased technology (5-17 year lives) $ 1,623 $ 1,513 Less: accumulated amortization (1,388 ) (1,334 ) Purchased technology, net $ 235 $ 179 Goodwill $ 185 $ 185 With respect to our trademark and brand name, we continue to market products, release new products and product extensions and maintain and promote these trademarks and brand name in the marketplace through legal registration and such methods as advertising, medical education and trade shows. Based on our annual impairment testing performed, these trademarks and brand names will generate cash flow for an indefinite period of time. Therefore, we believe our trademarks and brand name intangible assets are not impaired. Goodwill results from our acquisition of Bovie Bulgaria, EOOD. Amortization of purchased technology was $27,000 and $54,000 for the three and six months ended June 30, 2018 and 2017 , respectively. Amortization expense is classified within selling, general and administration expenses in the consolidated statements of operations. |
RECENT ACCOUNTING PRONOUNCEMENT
RECENT ACCOUNTING PRONOUNCEMENTS | 6 Months Ended |
Jun. 30, 2018 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
RECENT ACCOUNTING PRONOUNCEMENTS | RECENT ACCOUNTING PRONOUNCEMENTS In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . The purpose of this ASU is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this ASU, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit’s fair value. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, however we have chosen not to do so. The amendment is not expected to have a material impact on our financial condition or results of operations. ASU No. 2016-18, Restricted Cash Flows provides guidance on the presentation of restricted cash and restricted cash equivalents, which are now included with cash and cash equivalents when reconciling the beginning and ending cash amounts shown on the statements of cash flows. Using the retrospective transition method required under the standard, the Company has adjusted the presentation of its Condensed Consolidated Statements of Cash Flows for all periods presented. The adoption of ASU No. 2016-18 did not have any other impact on the Company’s Consolidated Financial Statements. The following table provides additional detail by financial statement line item of the ASU 2016-18 impact in our Consolidated Statement of Cash Flows for the six months ended June 30, 2018 and 2017 : (In thousands) As Reported (Pre-Adoption) ASU 2016-18 Reported (Post Adoption) Six Months Ended June 30, 2018 Cash, cash equivalents and restricted cash, beginning of period $ 9,949 $ 719 $ 10,668 Six Months Ended June 30, 2017 Net change in cash, cash equivalents and restricted cash $ (4,164 ) $ — $ (4,164 ) Cash, cash equivalents and restricted cash, beginning of period 14,456 779 15,235 Cash, cash equivalents and restricted cash, end of period $ 10,292 $ 779 $ 11,071 ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on our consolidated financial statements or disclosures. |
EARNINGS PER SHARE
EARNINGS PER SHARE | 6 Months Ended |
Jun. 30, 2018 | |
Earnings Per Share [Abstract] | |
EARNINGS PER SHARE | EARNINGS PER SHARE We compute basic earnings per share (“basic EPS”) by dividing the net income or loss by the weighted average number of common shares outstanding for the reporting period. Diluted earnings per share (“diluted EPS”) gives effect to all dilutive potential shares outstanding. The following table provides the computation of basic and diluted earnings per share. Three Months Ended Six Months Ended (in thousands, except per share data) 2018 2017 2018 2017 Numerator: Net loss available to common shareholders $ (272 ) $ (1,308 ) $ (1,207 ) $ (2,993 ) Effect of dilutive securities: Derivative liability - warrants — — — — Numerator for dilutive loss per common share $ (272 ) $ (1,308 ) $ (1,207 ) $ (2,993 ) Denominator: Weighted average shares used to compute basic loss per common share 32,890 30,860 32,884 30,860 Effect of dilutive securities: Derivative liability - warrants — — — — Denominator for dilutive loss per common share 32,890 30,860 32,884 30,860 Basic loss per common share $ (0.01 ) $ (0.04 ) $ (0.04 ) $ (0.10 ) Diluted loss per common share $ (0.01 ) $ (0.04 ) $ (0.04 ) $ (0.10 ) Anti-dilutive instruments excluded from diluted loss per common share: Warrants 14 3 10 16 Options 1,061 500 821 805 |
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION | 6 Months Ended |
Jun. 30, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION Under our stock option plans, our board of directors may grant options to purchase common shares to our key employees, officers, directors and consultants. We account for stock options in accordance with FASB ASC Topic 718, Compensation - Stock Compensation , with option expense amortized over the vesting period based on the trinomial lattice option-pricing model fair value on the grant date, which includes a number of estimates that affect the amount of our expense. We expensed approximately $377,000 and $749,000 in stock-based compensation during the three and six months ended June 30, 2018 , as compared with $182,000 and $341,000 for the three and six months ended June 30, 2017 , respectively. The status of our stock options and stock awards are summarized as follows: Number of options Weighted average exercise price Outstanding at December 31, 2017 4,860,157 $ 3.00 Granted 117,000 2.95 Exercised (37,250 ) 2.23 Canceled and forfeited (57,500 ) 6.55 Outstanding at June 30, 2018 4,882,407 $ 2.94 Common shares required to be issued upon the exercise of stock options and warrants would be issued from our authorized and unissued shares. We calculated the fair value of issued options utilizing a trinomial lattice with an expected life calculated via the simplified method as we do not have sufficient history to determine actual expected life. 2018 Grants Option value $ 1.46 - $ 1.96 Risk-free rate 1.9% Expected dividend yield — Expected volatility 68.8% Expected term (in years) 6 |
INCOME TAXES
INCOME TAXES | 6 Months Ended |
Jun. 30, 2018 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES The Company’s income tax expense was $13,000 and $24,000 with an effective tax rate of 0.0% for the three and six months ended June 30, 2018 , as compared to $4,000 and $9,000 with an effective tax rate of 0.0% for the three and six months ended June 30, 2017 . The Company’s effective tax rate differs from the statutory rate primarily due to the change in the valuation allowance on the Company’s net deferred tax assets with a finite life. As a result of historical losses, the Company recorded a valuation allowance on the net deferred tax asset with a finite life and does not anticipate recording an income tax benefit related to these deferred tax assets. The Company will reassess the realization of deferred tax assets each reporting period and will be able to reduce the valuation allowance to the extent that the financial results of these operations improve and it becomes more likely than not that the deferred tax assets are realizable. Management expects the gain from the sale of the Core business segment to Symmetry will utilize substantially all of the historical loss carryforwards and the valuation allowance on the deferred tax asset will be reversed during the third quarter of 2018, when the transaction is approved by the Company’s stockholders. For the six months ended June 30, 2018 , we do not believe we had any significant uncertain tax positions nor did we have any interest or penalties related to any significant uncertain tax positions. The Company is subject to U.S. federal income tax, state income tax and Bulgarian income tax. Until the respective statutes of limitations expire (which may be as much as 20 years while we have unused Net Operating Losses), we are subject to income tax audits in the jurisdictions in which we operate. |
COMMITMENTS, CONTINGENCIES AND
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS | 6 Months Ended |
Jun. 30, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS | COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS Property and Rental Agreements In March 2014, we signed a lease for offices located in Purchase, New York. We decided to consolidate operations in the Purchase, NY office with the facility in Clearwater, Florida. Based on this, we determined the office in Purchase, NY was no longer necessary and decided to cease all activity at the location. The remaining $119,000 of the lease was expensed in the fourth quarter of 2017 as part of severance and related expense. These remaining payments expensed in 2017 will be operational cash outflows in 2018 and 2019. In October 2015, pursuant to our acquisition of Bovie Bulgaria, we are obligated to pay a lease of $6,006 per month, expiring in December 2021, for 18,745 square feet of office, research and manufacturing space in Sofia, Bulgaria. The following is a schedule of approximate future minimum lease payments under operating leases as of June 30, 2018 : (In thousands) 2018 (remaining six months) $ 36 2019 72 2020 72 2021 72 Total $ 252 Litigation The medical device industry is characterized by frequent claims and litigation, and we are and may become subject to various claims, lawsuits and proceedings in the ordinary course of our business, including claims by current or former employees, distributors and competitors, and with respect to our products and product liability claims, lawsuits and proceedings. We are involved in a number of legal actions relating to the use of our J-Plasma technology. The outcomes of these legal actions are not within our complete control and may not be known for prolonged periods of time. In the opinion of management, the Company has meritorious defenses, and such claims are adequately covered by insurance, or are not expected, individually or in the aggregate, to result in a material, adverse effect on our financial condition. However, in the event that damages exceed the aggregate coverage limits of our policy or if our insurance carriers disclaim coverage, we believe it is possible that costs associated with these claims could have a material adverse impact on our consolidated earnings, financial position or cash flows. Purchase Commitments At June 30, 2018 , we had purchase commitments for inventories totaling approximately $5.4 million , substantially all of which is expected to be purchased by the end of 2018 . Concentrations Our ten largest customers accounted for approximately 36.7% and 29.2% of trade receivables as of June 30, 2018 and 2017 , respectively, and approximately 39.5% and 51.7% of net revenues for the six months ended June 30, 2018 and 2017 , respectively. For the six months ended June 30, 2018 , McKesson and National Distribution & Contracting Inc. accounted for 15.5% and 7.1% of sales, respectively, while for the same period in 2017 , McKesson and National Distribution & Contracting Inc. accounted for 15.5% and 10.1% of sales, respectively. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 6 Months Ended |
Jun. 30, 2018 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | RELATED PARTY TRANSACTIONS Several relatives of Nikolay Shilev, Bovie Bulgaria’s Managing Director, are considered related parties. Teodora Shileva, Mr. Shilev’s spouse, is an employee of the Company working in the Accounting department. Antoaneta Dimitrova Shileva-Toromanova, Mr. Shilev’s sister, is the Manager of Production and Human Resources. Svetoslav Shilev, Mr. Shilev’s son, is an Engineer in the Quality Assurance department. |
LONG TERM DEBT
LONG TERM DEBT | 6 Months Ended |
Jun. 30, 2018 | |
Debt Disclosure [Abstract] | |
LONG TERM DEBT | LONG TERM DEBT On June 28, 2016, the Company entered into a transaction with Bank of Tampa, a Florida banking corporation (“Lender”), wherein Lender amended the terms of a mortgage loan (“the Loan”) originally executed on March 20, 2014 with a principal amount of $3,592,000 . The Initial Maturity Date of the Loan was extended to July 20, 2019 from March 19, 2017, and the Extended Maturity Date was amended to July 20, 2024 from March 20, 2022. In addition, the Lender released as collateral to the Loan, the Company’s working capital accounts in exchange for a negative covenant limited to $2,000,000 of the aggregate indebtedness secured by these accounts. The obligations under the Loan are secured by a first mortgage and security interest in the Company’s Clearwater, Florida facility. In addition, the Company has pledged an interest in a certificate of deposit in the amount of $660,000 as additional collateral. The amount of the additional collateral required declines on a pro rata basis as principal is paid. Borrowings under the Loan bear interest at LIBOR plus 3.5% , with a fixed monthly principal payment of $19,956 . The interest rate at June 30, 2018 was 5.501% . The Loan documents contain customary financial covenants, including a covenant that the Company maintains a minimum liquidity, as defined, of $750,000 . Should we desire to extend the Loan beyond July 20, 2019, we must maintain a Debt Service Coverage Ratio for each of the preceding four quarters of not less than 1.0 to 1.0 . Our future contractual obligations for agreements with initial terms greater than one year are as follows: (In thousands) Long-term debt 2018 (remaining six months) $ 120 2019 2,454 Total $ 2,574 |
GEOGRAPHIC AND SEGMENT INFORMAT
GEOGRAPHIC AND SEGMENT INFORMATION | 6 Months Ended |
Jun. 30, 2018 | |
Segment Reporting [Abstract] | |
GEOGRAPHIC AND SEGMENT INFORMATION | GEOGRAPHIC AND SEGMENT INFORMATION Operating segments are aggregated into reportable segments only if they exhibit similar economic characteristics. In addition to similar economic characteristics, we also consider the following factors in determining the reportable segments: the nature of business activities, the management structure directly accountable to our chief operating decision maker for operating and administrative activities, availability of discrete financial information and information presented to the Board of Directors and investors. Our reportable segments are disclosed as principally organized and managed as three operating segments: Core, OEM and Advanced Energy. We adopted reportable segments to align with changes in how we manage our business, review operating performance and allocate resources as a result of the growth in Advanced Energy and the differing behavior of the Core and OEM product lines. The Corporate & Other category includes certain unallocated corporate, operational, research and development and marketing costs which were not specifically attributed to any reportable segment. Net assets are shared, therefore, not allocated to the reportable segments. The OEM segment is primarily development contract and product driven, all related expenses are recorded as cost of sales, therefore no segment specific operating expenses are incurred. Summarized financial information with respect to reportable segments is as follows: Three Months Ended June 30, 2018 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 7,784 $ 3,113 $ 578 $ — $ 11,475 Income (loss) from operations 2,666 (792 ) 302 (2,443 ) (267 ) Interest expense, net — — — (38 ) (38 ) Change in fair value of derivative liabilities — — — 46 46 Income tax expense — — — 13 13 Depreciation and amortization — — — 172 172 Three Months Ended June 30, 2017 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 7,488 $ 1,813 $ 498 $ — $ 9,799 Income (loss) from operations (1) 2,559 (1,284 ) 205 (2,786 ) (1,306 ) Interest expense, net — — — (36 ) (36 ) Change in fair value of derivative liabilities — — — 38 38 Income tax expense — — — 4 4 Depreciation and amortization — — — 178 178 Six Months Ended June 30, 2018 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 14,303 $ 5,742 $ 1,346 $ — $ 21,391 Income (loss) from operations 4,522 (1,370 ) 708 (4,991 ) (1,131 ) Interest expense, net — — — (72 ) (72 ) Change in fair value of derivative liabilities — — — 20 20 Income tax expense — — — 24 24 Depreciation and amortization — — — 371 371 Six Months Ended June 30, 2017 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 14,263 $ 2,420 $ 1,505 $ — $ 18,188 Income (loss) from operations (1) 4,772 (3,103 ) 708 (5,420 ) (3,043 ) Interest expense, net — — — (67 ) (67 ) Change in fair value of derivative liabilities — — — 126 126 Income tax expense — — — 9 9 Depreciation and amortization — — — 356 356 (1) During the first and second quarter of 2017, marketing expenses were presented as attributable only to the Corporate (Other) segment in the line Income (loss) from operations. It was subsequently determined that certain marketing expenses are attributable to specific segments. The disclosure of Income (loss) from operations was updated for the first and second quarter of 2017 to reflect marketing expense by segment. International sales represented approximately 15.5% and 17.4% of total revenues for the three and six months ended June 30, 2018 , respectively, as compared with 11.1% and 13.7% of total revenues for the three and six months ended June 30, 2017 . Substantially all of these sales are denominated in U.S. dollars. Revenue by geographic region, based on the “ship to” location on the invoice, are as follows: Three Months Ended Six Months Ended (In thousands) 2018 2017 2018 2017 Sales by Domestic and International Domestic $ 9,700 $ 8,708 $ 17,673 $ 15,700 International 1,775 1,091 3,718 2,488 Total $ 11,475 $ 9,799 $ 21,391 $ 18,188 |
SUBSEQUENT EVENT SUBSEQUENT EVE
SUBSEQUENT EVENT SUBSEQUENT EVENT | 6 Months Ended |
Jun. 30, 2018 | |
Subsequent Event [Line Items] | |
Subsequent events | SUBSEQUENT EVENTS On July 9, 2018, we entered into a definitive agreement with Specialty Surgical Instrumentation Inc., a subsidiary of Symmetry Surgical Inc. (“Symmetry”), pursuant to which the Company will divest and sell the Core business segment, including the Bovie ® brand and trademarks to Symmetry for gross proceeds of $97 million in cash. The asset purchase agreement was approved by the Company’s Board of Directors and is subject to customary closing conditions, including approval by the Company’s stockholders, and expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The Company is retaining and will continue to operate its Advanced Energy and OEM businesses, its facilities in Clearwater, FL and Sofia, Bulgaria, and certain intellectual property related to specialty generators. As of June 30, 2018, the Company concluded that the planned divestitures did not meet the criteria for assets held for sale – discontinued operations set forth in ASC No. 205–20, “Presentation of Financial Statements,” as stockholder approval is required prior to closing of the planned divestiture. The Company continues to classify these businesses in its continuing operations for all periods presented. |
BASIS OF PRESENTATION (Policies
BASIS OF PRESENTATION (Policies) | 6 Months Ended |
Jun. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Inventories | Inventories are stated at the lower of cost or market. Cost is determined on a first in, first out basis. Finished goods and work-in-process inventories include material, labor and overhead costs. Factory overhead costs are allocated to inventory manufactured in-house based upon labor hours. |
Recent Accounting Pronouncements | In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . The purpose of this ASU is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this ASU, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit’s fair value. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, however we have chosen not to do so. The amendment is not expected to have a material impact on our financial condition or results of operations. ASU No. 2016-18, Restricted Cash Flows provides guidance on the presentation of restricted cash and restricted cash equivalents, which are now included with cash and cash equivalents when reconciling the beginning and ending cash amounts shown on the statements of cash flows. Using the retrospective transition method required under the standard, the Company has adjusted the presentation of its Condensed Consolidated Statements of Cash Flows for all periods presented. The adoption of ASU No. 2016-18 did not have any other impact on the Company’s Consolidated Financial Statements. The following table provides additional detail by financial statement line item of the ASU 2016-18 impact in our Consolidated Statement of Cash Flows for the six months ended June 30, 2018 and 2017 : (In thousands) As Reported (Pre-Adoption) ASU 2016-18 Reported (Post Adoption) Six Months Ended June 30, 2018 Cash, cash equivalents and restricted cash, beginning of period $ 9,949 $ 719 $ 10,668 Six Months Ended June 30, 2017 Net change in cash, cash equivalents and restricted cash $ (4,164 ) $ — $ (4,164 ) Cash, cash equivalents and restricted cash, beginning of period 14,456 779 15,235 Cash, cash equivalents and restricted cash, end of period $ 10,292 $ 779 $ 11,071 ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on our consolidated financial statements or disclosures. |
INVENTORIES (Tables)
INVENTORIES (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
Inventory Disclosure [Abstract] | |
Schedule of inventory | Inventories consisted of the following: (In thousands) June 30, December 31, Raw materials $ 6,093 $ 5,163 Finished goods 3,301 3,276 Gross inventories 9,394 8,439 Less: reserve for obsolescence (1,861 ) (1,913 ) Net inventories $ 7,533 $ 6,526 |
BASIS OF PRESENTATION BASIS OF
BASIS OF PRESENTATION BASIS OF PRESENTATION (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
New Accounting Pronouncement, Early Adoption [Abstract] | |
New accounting pronouncement, early adoption | The following table provides additional detail by financial statement line item of the ASU 2016-18 impact in our Consolidated Statement of Cash Flows for the six months ended June 30, 2018 and 2017 : (In thousands) As Reported (Pre-Adoption) ASU 2016-18 Reported (Post Adoption) Six Months Ended June 30, 2018 Cash, cash equivalents and restricted cash, beginning of period $ 9,949 $ 719 $ 10,668 Six Months Ended June 30, 2017 Net change in cash, cash equivalents and restricted cash $ (4,164 ) $ — $ (4,164 ) Cash, cash equivalents and restricted cash, beginning of period 14,456 779 15,235 Cash, cash equivalents and restricted cash, end of period $ 10,292 $ 779 $ 11,071 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of intangible assets | Intangible assets consisted of the following: (In thousands) June 30, December 31, Brand name and trademark (life indefinite) $ 1,510 $ 1,510 Purchased technology (5-17 year lives) $ 1,623 $ 1,513 Less: accumulated amortization (1,388 ) (1,334 ) Purchased technology, net $ 235 $ 179 Goodwill $ 185 $ 185 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
Earnings Per Share [Abstract] | |
Basic and diluted earnings per share | The following table provides the computation of basic and diluted earnings per share. Three Months Ended Six Months Ended (in thousands, except per share data) 2018 2017 2018 2017 Numerator: Net loss available to common shareholders $ (272 ) $ (1,308 ) $ (1,207 ) $ (2,993 ) Effect of dilutive securities: Derivative liability - warrants — — — — Numerator for dilutive loss per common share $ (272 ) $ (1,308 ) $ (1,207 ) $ (2,993 ) Denominator: Weighted average shares used to compute basic loss per common share 32,890 30,860 32,884 30,860 Effect of dilutive securities: Derivative liability - warrants — — — — Denominator for dilutive loss per common share 32,890 30,860 32,884 30,860 Basic loss per common share $ (0.01 ) $ (0.04 ) $ (0.04 ) $ (0.10 ) Diluted loss per common share $ (0.01 ) $ (0.04 ) $ (0.04 ) $ (0.10 ) Anti-dilutive instruments excluded from diluted loss per common share: Warrants 14 3 10 16 Options 1,061 500 821 805 |
STOCK-BASED COMPENSATION (Table
STOCK-BASED COMPENSATION (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Summary of stock options and stock awards | The status of our stock options and stock awards are summarized as follows: Number of options Weighted average exercise price Outstanding at December 31, 2017 4,860,157 $ 3.00 Granted 117,000 2.95 Exercised (37,250 ) 2.23 Canceled and forfeited (57,500 ) 6.55 Outstanding at June 30, 2018 4,882,407 $ 2.94 |
Schedule of option fair value assumptions | 2018 Grants Option value $ 1.46 - $ 1.96 Risk-free rate 1.9% Expected dividend yield — Expected volatility 68.8% Expected term (in years) 6 |
COMMITMENTS, CONTINGENCIES AN25
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Future minimum lease payments under operating leases | The following is a schedule of approximate future minimum lease payments under operating leases as of June 30, 2018 : (In thousands) 2018 (remaining six months) $ 36 2019 72 2020 72 2021 72 Total $ 252 |
LONG TERM DEBT (Tables)
LONG TERM DEBT (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
Debt Disclosure [Abstract] | |
Summary of long-term debt | Our future contractual obligations for agreements with initial terms greater than one year are as follows: (In thousands) Long-term debt 2018 (remaining six months) $ 120 2019 2,454 Total $ 2,574 |
GEOGRAPHIC AND SEGMENT INFORM27
GEOGRAPHIC AND SEGMENT INFORMATION (Tables) | 6 Months Ended |
Jun. 30, 2018 | |
Segment Reporting [Abstract] | |
Schedule of reporting information by segment | Summarized financial information with respect to reportable segments is as follows: Three Months Ended June 30, 2018 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 7,784 $ 3,113 $ 578 $ — $ 11,475 Income (loss) from operations 2,666 (792 ) 302 (2,443 ) (267 ) Interest expense, net — — — (38 ) (38 ) Change in fair value of derivative liabilities — — — 46 46 Income tax expense — — — 13 13 Depreciation and amortization — — — 172 172 Three Months Ended June 30, 2017 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 7,488 $ 1,813 $ 498 $ — $ 9,799 Income (loss) from operations (1) 2,559 (1,284 ) 205 (2,786 ) (1,306 ) Interest expense, net — — — (36 ) (36 ) Change in fair value of derivative liabilities — — — 38 38 Income tax expense — — — 4 4 Depreciation and amortization — — — 178 178 Six Months Ended June 30, 2018 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 14,303 $ 5,742 $ 1,346 $ — $ 21,391 Income (loss) from operations 4,522 (1,370 ) 708 (4,991 ) (1,131 ) Interest expense, net — — — (72 ) (72 ) Change in fair value of derivative liabilities — — — 20 20 Income tax expense — — — 24 24 Depreciation and amortization — — — 371 371 Six Months Ended June 30, 2017 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 14,263 $ 2,420 $ 1,505 $ — $ 18,188 Income (loss) from operations (1) 4,772 (3,103 ) 708 (5,420 ) (3,043 ) Interest expense, net — — — (67 ) (67 ) Change in fair value of derivative liabilities — — — 126 126 Income tax expense — — — 9 9 Depreciation and amortization — — — 356 356 (1) During the first and second quarter of 2017, marketing expenses were presented as attributable only to the Corporate (Other) segment in the line Income (loss) from operations. It was subsequently determined that certain marketing expenses are attributable to specific segments. The disclosure of Income (loss) from operations was updated for the first and second quarter of 2017 to reflect marketing expense by segment. |
Schedule of revenue by geographic area | Revenue by geographic region, based on the “ship to” location on the invoice, are as follows: Three Months Ended Six Months Ended (In thousands) 2018 2017 2018 2017 Sales by Domestic and International Domestic $ 9,700 $ 8,708 $ 17,673 $ 15,700 International 1,775 1,091 3,718 2,488 Total $ 11,475 $ 9,799 $ 21,391 $ 18,188 |
INVENTORIES (Details)
INVENTORIES (Details) - USD ($) $ in Thousands | Jun. 30, 2018 | Dec. 31, 2017 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 6,093 | $ 5,163 |
Finished goods | 3,301 | 3,276 |
Gross inventories | 9,394 | 8,439 |
Less: reserve for obsolescence | (1,861) | (1,913) |
Net inventories | $ 7,533 | $ 6,526 |
INTANGIBLE ASSETS (Details)
INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | Dec. 31, 2017 | |
Finite-Lived Intangible Assets [Line Items] | |||||
Purchased technology, net | $ 235 | $ 235 | $ 179 | ||
Goodwill | 185 | 185 | 185 | ||
Amortization of Intangible Assets | 27 | $ 27 | 54 | $ 54 | |
Brand name and trademark (life indefinite) | |||||
Indefinite-lived Intangible Assets [Line Items] | |||||
Brand name and trademark | 1,510 | 1,510 | 1,510 | ||
Purchased technology | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Purchased technology | 1,623 | 1,623 | 1,513 | ||
Less: accumulated amortization | (1,388) | (1,388) | (1,334) | ||
Purchased technology, net | $ 235 | $ 235 | $ 179 | ||
Purchased technology | Minimum | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Intangible asset, useful life (in years) | 5 years | ||||
Purchased technology | Maximum | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Intangible asset, useful life (in years) | 17 years |
RECENT ACCOUNTING PRONOUNCEME30
RECENT ACCOUNTING PRONOUNCEMENTS BASIS OF PRESENTATION (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2018 | Jun. 30, 2017 | |
New Accounting Pronouncement, Early Adoption [Line Items] | ||
Net change in cash, cash equivalents and restricted cash | $ (2,133) | $ (4,164) |
Cash, cash equivalents and restricted cash, beginning of period | 10,668 | 15,235 |
Cash, cash equivalents and restricted cash, end of period | 8,535 | 11,071 |
Adjustments for New Accounting Principle, Early Adoption [Member] | ||
New Accounting Pronouncement, Early Adoption [Line Items] | ||
Net change in cash, cash equivalents and restricted cash | 0 | |
Cash, cash equivalents and restricted cash, beginning of period | 719 | 779 |
Cash, cash equivalents and restricted cash, end of period | 779 | |
Previously reported | ||
New Accounting Pronouncement, Early Adoption [Line Items] | ||
Net change in cash, cash equivalents and restricted cash | (4,164) | |
Cash, cash equivalents and restricted cash, beginning of period | $ 9,949 | 14,456 |
Cash, cash equivalents and restricted cash, end of period | $ 10,292 |
EARNINGS PER SHARE (Details)
EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |
Numerator: | ||||
Net loss available to common shareholders | $ (272) | $ (1,308) | $ (1,207) | $ (2,993) |
Derivative liability - warrants | 0 | 0 | 0 | 0 |
Numerator for dilutive loss per common share | $ (272) | $ (1,308) | $ (1,207) | $ (2,993) |
Denominator: | ||||
Weighted average shares used to compute basic loss per common share (in shares) | 32,890 | 30,860 | 32,884 | 30,860 |
Derivative liability - warrants (in shares) | 0 | 0 | 0 | 0 |
Denominator for diluted loss per common share (in shares) | 32,890 | 30,860 | 32,884 | 30,860 |
Earnings Per Share, Basic and Diluted [Abstract] | ||||
Basic loss per common share (in dollars per share) | $ (0.01) | $ (0.04) | $ (0.04) | $ (0.10) |
Diluted loss per common share (in dollars per share) | $ (0.01) | $ (0.04) | $ (0.04) | $ (0.10) |
Warrants | ||||
Anti-dilutive securities excluded from diluted loss per share | ||||
Anti-dilutive securities excluded from diluted loss per share | 14 | 3 | 10 | 16 |
Options | ||||
Anti-dilutive securities excluded from diluted loss per share | ||||
Anti-dilutive securities excluded from diluted loss per share | 1,061 | 500 | 821 | 805 |
STOCK-BASED COMPENSATION - NARR
STOCK-BASED COMPENSATION - NARRATIVE (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||
Stock based compensation | $ 377 | $ 182 | $ 749 | $ 341 |
STOCK-BASED COMPENSATION - SUMM
STOCK-BASED COMPENSATION - SUMMARY OF STOCK OPTIONS (Details) | 6 Months Ended |
Jun. 30, 2018$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | |
Outstanding, beginning of period (in shares) | shares | 4,860,157 |
Granted (in shares) | shares | 117,000 |
Exercised (in shares) | shares | (37,250) |
Canceled and forfeited (in shares) | shares | (57,500) |
Outstanding, end of period (in shares) | shares | 4,882,407 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | |
Outstanding, beginning of period (in dollars per share) | $ / shares | $ 3 |
Granted (in dollars per share) | $ / shares | 2.95 |
Exercised (in dollars per share) | $ / shares | 2.23 |
Canceled and forfeited (in dollars per shares) | $ / shares | 6.55 |
Outstanding, end of period (in dollars per share) | $ / shares | $ 2.94 |
STOCK-BASED COMPENSATION - FAIR
STOCK-BASED COMPENSATION - FAIR VALUE ASSUMPTIONS (Details) | 6 Months Ended |
Jun. 30, 2018$ / shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Risk-free rate (as a percent) | 1.90% |
Expected dividend yield (as a percent) | 0.00% |
Expected volatility (as a percent) | 68.80% |
Expected term (in years) | 6 years |
Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Option value (in dollars per share) | $ 1.46 |
Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Option value (in dollars per share) | $ 1.96 |
INCOME TAXES - EFFECTIVE TAX RA
INCOME TAXES - EFFECTIVE TAX RATE (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |
Income Tax Disclosure [Abstract] | ||||
Income tax expense | $ 13 | $ 4 | $ 24 | $ 9 |
Effective income tax rate, percent (as a percent) | 0.00% | 0.00% | 0.00% | 0.00% |
COMMITMENTS, CONTINGENCIES AN36
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS - FUTURE MINIMUM LEASE PAYMENTS (Details) $ in Thousands | Jun. 30, 2018USD ($) |
Future minimum lease payments under operating leases | |
2018 (remaining six months) | $ 36 |
2,019 | 72 |
2,020 | 72 |
2,021 | 72 |
Total | $ 252 |
COMMITMENTS, CONTINGENCIES AN37
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS - NARRATIVE (Details) | 6 Months Ended | |||
Jun. 30, 2018USD ($) | Jun. 30, 2017 | Dec. 31, 2017USD ($) | Oct. 31, 2015USD ($)ft² | |
Other Commitments [Line Items] | ||||
Purchase commitments for inventories | $ 5,400,000 | |||
Accrued severance and related | 439,000 | $ 1,242,000 | ||
Purchase, NY | ||||
Other Commitments [Line Items] | ||||
Accrued severance and related | $ 119,000 | |||
Customer concentration risk | Trade receivable | 10 Largest Customers | ||||
Other Commitments [Line Items] | ||||
Concentration receivable risk (as a percent) | 36.70% | 29.20% | ||
Customer concentration risk | Sales Revenue | 10 Largest Customers | ||||
Other Commitments [Line Items] | ||||
Concentration receivable risk (as a percent) | 39.50% | 51.70% | ||
Customer concentration risk | Sales Revenue | McKesson | ||||
Other Commitments [Line Items] | ||||
Concentration receivable risk (as a percent) | 15.50% | 15.50% | ||
Customer concentration risk | Sales Revenue | National Distribution & Contracting Inc. | ||||
Other Commitments [Line Items] | ||||
Concentration receivable risk (as a percent) | 7.10% | 10.10% | ||
Sophia, Bulgaria | ||||
Other Commitments [Line Items] | ||||
Area of real estate property (in square feet) | ft² | 18,745 | |||
Monthly cost of office space | $ 6,006 |
LONG TERM DEBT - NARRATIVE (Det
LONG TERM DEBT - NARRATIVE (Details) - Mortgages | Jun. 28, 2016USD ($) | Jun. 30, 2018USD ($) |
Debt Instrument [Line Items] | ||
Mortgage loan, principal amount | $ 3,592,000 | |
Certificate of deposit, amount pledged as collateral | $ 660,000 | |
Fixed monthly principal payment | 19,956 | |
Effective interest rate (as a percent) | 5.501% | |
Debt covenant, minimum liquidity | $ 750,000 | |
Debt service coverage ratio for preceding four quarters for extension of loan | 1 | |
London Interbank Offered Rate (LIBOR) | ||
Debt Instrument [Line Items] | ||
Basis spread on variable rate (as a percent) | 3.50% | |
Secured Debt | ||
Debt Instrument [Line Items] | ||
Maximum working capital accounts | $ 2,000,000 |
LONG TERM DEBT - FUTURE MATURIT
LONG TERM DEBT - FUTURE MATURITIES (Details) $ in Thousands | Jun. 30, 2018USD ($) |
Long-term Debt, Fiscal Year Maturity [Abstract] | |
2018 (remaining six months) | $ 120 |
2,019 | 2,454 |
Total long-term debt | $ 2,574 |
GEOGRAPHIC AND SEGMENT INFORM40
GEOGRAPHIC AND SEGMENT INFORMATION - REPORTABLE SEGMENT (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |||
Segment Reporting Information [Line Items] | ||||||
Sales | $ 11,475 | $ 9,799 | $ 21,391 | $ 18,188 | ||
Income (loss) from operations | (267) | (1,306) | (1,131) | (3,043) | ||
Interest expense, net | (38) | (36) | (72) | (67) | ||
Change in fair value of derivative liabilities | 46 | 38 | 20 | 126 | ||
Income tax expense | 13 | 4 | 24 | 9 | ||
Depreciation and amortization | 172 | 178 | 371 | 356 | ||
Operating Segments | Core | ||||||
Segment Reporting Information [Line Items] | ||||||
Sales | 7,784 | 7,488 | 14,303 | 14,263 | ||
Income (loss) from operations | 2,666 | 2,559 | [1] | 4,522 | 4,772 | [1] |
Interest expense, net | 0 | 0 | 0 | 0 | ||
Change in fair value of derivative liabilities | 0 | 0 | 0 | 0 | ||
Income tax expense | 0 | 0 | 0 | 0 | ||
Depreciation and amortization | 0 | 0 | 0 | 0 | ||
Operating Segments | Advanced Energy | ||||||
Segment Reporting Information [Line Items] | ||||||
Sales | 3,113 | 1,813 | 5,742 | 2,420 | ||
Income (loss) from operations | (792) | (1,284) | [1] | (1,370) | (3,103) | [1] |
Interest expense, net | 0 | 0 | 0 | 0 | ||
Change in fair value of derivative liabilities | 0 | 0 | 0 | 0 | ||
Income tax expense | 0 | 0 | 0 | 0 | ||
Depreciation and amortization | 0 | 0 | 0 | 0 | ||
Operating Segments | OEM | ||||||
Segment Reporting Information [Line Items] | ||||||
Sales | 578 | 498 | 1,346 | 1,505 | ||
Income (loss) from operations | 302 | 205 | [1] | 708 | 708 | [1] |
Interest expense, net | 0 | 0 | 0 | 0 | ||
Change in fair value of derivative liabilities | 0 | 0 | 0 | 0 | ||
Income tax expense | 0 | 0 | 0 | 0 | ||
Depreciation and amortization | 0 | 0 | 0 | 0 | ||
Corporate (Other) | ||||||
Segment Reporting Information [Line Items] | ||||||
Sales | 0 | 0 | 0 | 0 | ||
Income (loss) from operations | (2,443) | (2,786) | [1] | (4,991) | (5,420) | [1] |
Interest expense, net | (38) | (36) | (72) | (67) | ||
Change in fair value of derivative liabilities | 46 | 38 | 20 | 126 | ||
Income tax expense | 13 | 4 | 24 | 9 | ||
Depreciation and amortization | $ 172 | $ 178 | $ 371 | $ 356 | ||
[1] | During the first and second quarter of 2017, marketing expenses were presented as attributable only to the Corporate (Other) segment in the line Income (loss) from operations. It was subsequently determined that certain marketing expenses are attributable to specific segments. The disclosure of Income (loss) from operations was updated for the first and second quarter of 2017 to reflect marketing expense by segment. |
GEOGRAPHIC AND SEGMENT INFORM41
GEOGRAPHIC AND SEGMENT INFORMATION - GEOGRAPHIC (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |
Segment Reporting Information [Line Items] | ||||
Sales | $ 11,475 | $ 9,799 | $ 21,391 | $ 18,188 |
Domestic | ||||
Segment Reporting Information [Line Items] | ||||
Sales | 9,700 | 8,708 | 17,673 | 15,700 |
International | ||||
Segment Reporting Information [Line Items] | ||||
Sales | $ 1,775 | $ 1,091 | $ 3,718 | $ 2,488 |
GEOGRAPHIC AND SEGMENT INFORM42
GEOGRAPHIC AND SEGMENT INFORMATION - NARRATIVE (Details) - segment | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2018 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | |
Segment Reporting [Abstract] | ||||
Number of operating segments (in segments) | 3 | |||
Geographic concentration risk | Sales Revenue | International customers | ||||
Concentration Risk [Line Items] | ||||
Concentration receivable risk (as a percent) | 15.50% | 11.10% | 17.40% | 13.70% |
SUBSEQUENT EVENT (Details)
SUBSEQUENT EVENT (Details) $ in Millions | Jul. 09, 2018USD ($) |
Subsequent Event [Member] | |
Subsequent Event [Line Items] | |
Gross cash consideration | $ 97 |